07:12 AM EST, 02/20/2025 (MT Newswires) -- Insmed ( INSM ) reported a Q4 loss Thursday of $1.32 per diluted share, wider than a loss of $1.28 a year earlier.

Analysts polled by Capital IQ expected a loss of $1.17.

Revenue for the quarter ended Dec. 31 was $104.4 million, compared with $83.7 million a year earlier.

Analysts surveyed by Capital IQ expected $102.1 million.

As of Dec. 31, 2024, Insmed ( INSM ) had cash, cash equivalents, and marketable securities totaling about $1.4 billion.